At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
OSRH OSR Holdings
Closed Good Friday 04-17 16:00:00 EDT
1.33
-0.02
-1.48%
盘后1.39
+0.06+4.51%
19:55 EDT
| High1.39 | Low1.33 | Vol58.63K |
| Open1.35 | D1 Closing1.35 | Amplitude4.44% |
| Mkt Cap25.64M | Tradable Cap6.00M | Total Shares19.28M |
| T/O79.49K | T/O Rate1.30% | Tradable Shares4.51M |
| P/B-- | ROE-- | EPS-0.09 |
| 52wk High13.40 | 52wk Low1.30 | P/E-15.41 |
| Dividend0.00 | Div.Yield0.00 | ROA-- |
Loading ...
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology
PR Newswire · 04-09
Top Midday Gainers
MT Newswires Live · 04-03
OSR Holdings Signs $80 Million Stock Deal to Support Brain Cancer Research: Shares Up
MT Newswires Live · 04-03
BRIEF-OSR Holdings Entered Common Stock Purchase Agreement With White Lion GBM Innovation Fund
Reuters · 04-03
Osr Holdings, Inc. (Nasdaq: Osrh) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With an Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies
THOMSON REUTERS · 04-03
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies
PR Newswire · 04-03
Top Midday Gainers
MT Newswires Live · 03-26
Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings
Benzinga · 03-26
OSR Holdings Shares Double on Trial Results
Dow Jones · 03-26
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump
MT Newswires Live · 03-26
BRIEF-Vaximm AG Reports Phase 2A Results For VXM01 And Avelumab Combo In Glioblastoma
Reuters · 03-26
Vaximm Ag- Decreased Tumor Size Observed in Responding Patients
THOMSON REUTERS · 03-26
Vaximm Ag - Phase 2a Trial Shows Good Safety and Tolerability Profile
THOMSON REUTERS · 03-26
Vaximm Ag - No Serious Adverse Events Attributed to Vxm01
THOMSON REUTERS · 03-26
Vaximm Ag, an Osr Company, Announces Results From Phase 2a Trial of Vxm01 and Avelumab Combination Therapy in Glioblastoma
THOMSON REUTERS · 03-26
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
PR Newswire · 03-26
Osr Holdings Appoints DR. Constance HÖFer as Chief Scientific Officer
THOMSON REUTERS · 03-25
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
PR Newswire · 03-25
Osr Holdings Inc - on Feb 25, Entered Common Stock Purchase Agreement With White Lion GBM Innovation Fund
THOMSON REUTERS · 02-28
OSR Holdings Ends Shell Status with Share Issuance
TIPRANKS · 02-21
Introduction
Company Name.
OSR Holdings
Affiliated Markets:
NASDAQ
Listing Date:
2023-03-17
Main Business:
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App